| 000 | 01859 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514215621.0 | ||
| 264 | 0 | _c20050408 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0161-5505 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEschmann, Susanne-Martina | |
| 245 | 0 | 0 |
_aPrognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cFeb 2005 |
||
| 300 |
_a253-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Validation Study | ||
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdiagnostic imaging |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorine Radioisotopes |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMisonidazole _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xstatistics & numerical data |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPaulsen, Frank | |
| 700 | 1 | _aReimold, Matthias | |
| 700 | 1 | _aDittmann, Helmut | |
| 700 | 1 | _aWelz, Stefan | |
| 700 | 1 | _aReischl, Gerald | |
| 700 | 1 | _aMachulla, Hans-Juergen | |
| 700 | 1 | _aBares, Roland | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 46 _gno. 2 _gp. 253-60 |
|
| 999 |
_c15372460 _d15372460 |
||